| ²é¿´: 517 | »Ø¸´: 3 | ||
ϲ»¶Ê¯Í·Ìú³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÎÄÏ×£¬ÒòΪÏÂÔØ²»ÏÂÀ´£¬Çó°ïÖú,ÓÉÓÚ½ð±Ò²»¶à£¬Ö»ÄÜÒ»¸öÁË
|
|
1.Ko, Y. L.Lien, W. P.Chen, J. J.Wu, C. W.No evidence for linkage of familial hypertrophic cardiomyopathy and chromosome 14q1 locus D14S26 in a Chinese family: evidence for genetic heterogeneity.1992 2 Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy.2013 3.Echocardiographic study of double mutations of myosin-binding protein C3 gene in Chinese patients with familial hypertrophic cardiomyopathy.2013 4.Progress in the molecular genetics of hypertrophic cardiomyopathy: a mini-review 5.[Genetic and clinical study of three Chinese pedigrees with Fabry disease] 6.Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy 7.Myocardial contractile and metabolic properties of familial hypertrophic cardiomyopathy caused by cardiac troponin I gene mutations: a simulation study 8.Danon disease: focusing on heart 9.Detection of somatic and germline mosaicism for the LAMP2 gene mutation c.808dupG in a Chinese family with Danon disease 10.Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy 11.Correlation of cardiac troponin T gene mutations to hypertrophic cardiomyopathy in Chinese patients |
» ²ÂÄãϲ»¶
Çó¹ºÓлú¹è¼¾ï§ÑÎ
ÒѾÓÐ2È˻ظ´
ÄÉÃ×ÖÆ¼Á°ü·âÂʺÍÔØÒ©Á¿¼ÆËã
ÒѾÓÐ5È˻ظ´
·¨Ò½Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ183È˻ظ´
ÈÎÖ°¸ßУûÓÐ˶²©Ñ§Î»µã£¬ÊÇ·ñÓ¦¿¼ÂÇÌø²Û£¿
ÒѾÓÐ20È˻ظ´
Çཷһö£¬ÇëÎʽèµ÷µ½»ù½ðί¶Ô¸öÈËÓÐÓÃÂð£¿
ÒѾÓÐ37È˻ظ´
339·Ö»¤Àí¿¼ÉúÉêÇëµ÷¼ÁµÄ×Ô¼öÐÅ
ÒѾÓÐ0È˻ظ´
ÇóÖúÒÀÌæÃ×ÐÇ£¬ÄÎÌæÃ×ÐÇ£¬ÒìÅÁÃ×ÐǵݬÃÀÊËÊý¾Ý
ÒѾÓÐ0È˻ظ´
Methoxy-PEG-Silane£¬MPEG-Silane£¬¼×Ñõ»ùPEG¹èÍé
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
µÚһƪSCI¼´½«Í깤£¬ÇóÖú²Î¿¼ÎÄÏ×Ôõôд½øÈ¥£¿×¢£ºÈô×îÖÕ·¢±í£¬É¢¾¡½ð±ÒлÖîλ
ÒѾÓÐ10È˻ظ´
ÈçºÎ½øÐÐË®ÖÊÑùµãµÄ¾ÛÀà·ÖÎö£¬½ð±Ò²»¶à£¬¹òÇó°ïæ½â¾ö£¬Ô½ÏêϸԽºÃ~~
ÒѾÓÐ8È˻ظ´
±¾ÈËÓ¢Óï²»ºÃ£¬ÐèÒªÏÂÃæµÄÓ¢ÎÄ×ÊÁÏ£¬Çó´óÉñ·ÒëÁ½¶ÎÎÄÏס£¸Ð¼¤²»¾¡£¡£¡
ÒѾÓÐ3È˻ظ´
Çó´ïÈ˰ïæ·ÒëһƪÎÄÏ×£¬Ö»ÓÐ5½ð±Ò£¬ÐÂÈË£¬¹òлÁË
ÒѾÓÐ3È˻ظ´
cnkiÎÄÏ×´ò²»¿ª£¬Çó³æ×Ó°ïæ¿´¿´´ò¿ª²¢×ª³Épdf¸ñʽ£¬Ð»Ð»£¡£¡
ÒѾÓÐ5È˻ظ´
ÇóÖú£ºÎªÊ²Ã´½ñÌìÎÄÏ×ÏÂÔØÊ±µã»÷PDFÁ´½Óºó²»³öÏֿɱ£´æÎÄÏ×
ÒѾÓÐ6È˻ظ´
µ½ÄÄÀïÄܹ»ÕÒµ½ºÃµÄÖÐÎÄÎÄÏ× ÎÒÊǶíÓïÉú Ö»»á¶íÓï Ó¢ÎÄÎÄÏ׿´²»¶® Çó´óÉñ°ïæ
ÒѾÓÐ18È˻ظ´
ÐÂÈËÇóÖú£ºElsevierͶ¸å¸ñʽÖеÄÎÊÌ⣬figure caption£¬²Î¿¼ÎÄÏ׵ȣ¬²»Ê¤¸Ð¼¤°¡£¡
ÒѾÓÐ22È˻ظ´
±¾ÈËϵ¿ÆÑÐСÉú£¬ÏÖÓûÇë½Ì²éÔÄÎÄÏ×·½ÃæµÄ·½·¨£¬ÈôÓö¹óÈ˰ïÖú£¬Ô¸½«½ð±ÒÈ«²¿ÔùÓë
ÒѾÓÐ12È˻ظ´
ÎÄÏ×ÇóÖú£¬²»ÓóîÀ²£¡
ÒѾÓÐ31È˻ظ´
¡¾ÇóÖú¡¿½ð±ÒÇóÕý½â£ºÍ¬Ò»¸ö¹úÍâѧУofferÊDz»ÊÇÓÐͳһµÄÑùʽ£¿£¿
ÒѾÓÐ9È˻ظ´
ÇóÖú£¬CNKIѧÊõ²»¶ËÎÄÏ×¼ì²âϵͳÕ˺Å
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿Çó¼ÆËãË®Àë½â³ÉÇâÀë×ÓÒÔ¼°ÇâÑõ¸ùÀë×ÓµÄìʱäµÄ¸ß˹¼ÆËã·½·¨£¨½ð±Ò²»¶à£¬É¢Ê®¸ö
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿Çó¹ØÓÚ²»Í¬·´Ó¦ÎïŨ¶ÈµÃµ½²»Í¬ÐÎò»òÊǽᾧ³Ì¶È²»Í¬µÄ²úÎïµÄÎÄÏ×
ÒѾÓÐ9È˻ظ´
ÇóÖú---CAJÔĶÁÆ÷Ôõô´ò²»¿ªÎÄÏ×ÁË£¿
ÒѾÓÐ5È˻ظ´
80¸ö½ð±ÒÇóÖúÎÄÏ×10ƪ
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿¿Õ¼äȺÓëÎÄÏ×ÖеIJ»Ò»Ñù£¬Ôõô°ì£¿
ÒѾÓÐ21È˻ظ´
µÂÓïÎÄÏ×·ÒëÇóÖú£¡¼±£¡100½ð±Ò¹»Â𣿲»¹»ÔÙ¼Ó£¡
ÒѾÓÐ16È˻ظ´

Á÷Ë®ÓÐÇé
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
ÓÐÇé¾ÓÖ÷ÈË
- Ó¦Öú: 207 (´óѧÉú)
- ½ð±Ò: 21223.4
- É¢½ð: 600
- ºì»¨: 55
- ɳ·¢: 142
- Ìû×Ó: 7675
- ÔÚÏß: 397.9Сʱ
- ³æºÅ: 2688832
- ×¢²á: 2013-09-28
- ÐÔ±ð: GG
- רҵ: µ¼º½¡¢ÖƵ¼Óë´«¸Ð¼¼Êõ

2Â¥2013-11-09 13:11:33
ϲ»¶Ê¯Í·
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 144
- Ìû×Ó: 64
- ÔÚÏß: 7.9Сʱ
- ³æºÅ: 1678376
- ×¢²á: 2012-03-09
- ÐÔ±ð: MM
- רҵ: »ùÒò×éѧ

3Â¥2013-11-09 13:17:09
Davidzjy
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 209 (´óѧÉú)
- ½ð±Ò: 6632.3
- É¢½ð: 431
- ºì»¨: 22
- Ìû×Ó: 965
- ÔÚÏß: 393.2Сʱ
- ³æºÅ: 1887475
- ×¢²á: 2012-07-11
- רҵ: ÈËÀàÒÅ´«Ñ§
4Â¥2013-11-09 16:25:18













»Ø¸´´ËÂ¥